Google Partners With Med Tech Company To Develop AI Breast Cancer Screening Tools
Published on November 29, 2022 at 12:15AM
Google announced today that it has licensed its AI research model for breast cancer screening to medical technology company iCAD. This is the first time Google is licensing the technology, with the hopes that it will eventually lead to more accurate breast cancer detection and risk assessment. From a report: The two companies aim to eventually deploy the technology in real-world clinical settings -- targeting a "2024 release," Google communications manager Nicole Linton told The Verge in an email. Commercial deployment, however, still depends on how successful continued research and testing are. "We will move deliberately and test things as we go," Linton said in the email. The partnership builds on Google's prior work to improve breast cancer detection. Back in 2020, Google researchers published a paper in the journal Nature that found that its AI system outperformed several radiologists in identifying signs of breast cancer. The model reduced false negatives by up to 9.4 percent and reduced false positives by up to 5.7 percent among thousands of mammograms studied. iCAD plans to incorporate Google's mammography AI research model into iCAD's existing tools. The first is its "ProFound AI" tool that analyzes images from digital breast tomosynthesis (DBT), an advanced imaging technique sometimes called "3D mammography." The tool scans DBT images to look for malignant soft tissue densities and calcifications. iCAD also plans to use Google's model with its risk evaluation tool, which the company says provides personalized breast cancer risk estimation tailored to each person.
Published on November 29, 2022 at 12:15AM
Google announced today that it has licensed its AI research model for breast cancer screening to medical technology company iCAD. This is the first time Google is licensing the technology, with the hopes that it will eventually lead to more accurate breast cancer detection and risk assessment. From a report: The two companies aim to eventually deploy the technology in real-world clinical settings -- targeting a "2024 release," Google communications manager Nicole Linton told The Verge in an email. Commercial deployment, however, still depends on how successful continued research and testing are. "We will move deliberately and test things as we go," Linton said in the email. The partnership builds on Google's prior work to improve breast cancer detection. Back in 2020, Google researchers published a paper in the journal Nature that found that its AI system outperformed several radiologists in identifying signs of breast cancer. The model reduced false negatives by up to 9.4 percent and reduced false positives by up to 5.7 percent among thousands of mammograms studied. iCAD plans to incorporate Google's mammography AI research model into iCAD's existing tools. The first is its "ProFound AI" tool that analyzes images from digital breast tomosynthesis (DBT), an advanced imaging technique sometimes called "3D mammography." The tool scans DBT images to look for malignant soft tissue densities and calcifications. iCAD also plans to use Google's model with its risk evaluation tool, which the company says provides personalized breast cancer risk estimation tailored to each person.
Read more of this story at Slashdot.
Comments
Post a Comment